Cetuximab combined with natural killer cells therapy: an alternative to chemoradiotherapy for patients with advanced non-small cell lung cancer (NSCLC).
Year: 2018
Type: article
Abstract: < 0.05). Combination therapy could be an alternative to chemoradiotherapy for patients with advanced NSCLC.
Source: Europe PMC (PubMed Central)
Authors: Shuzhen Liang, Mao Lin, Lizhi Niu, Kecheng Xu, Xiaohua Wang, Yingqing Liang, Mingjie Zhang, Duanming Du, Jibing Chen
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2990476997